lobbying_activities: 2018453

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2018453	af26dd60-0670-4c2f-a7e8-3db38ca2ca49	3T	ORGANOVO, INC.	401104008	ORGANOVO, INC.	2017	third_quarter	HCR	Issues related to the reauthorization of the Prescription Drug User Fee Act. Issues related to the implementation of PL 114-255, the 21st Century Cures Act.	Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		40000	0	1	2017-08-31T15:56:15.473000-04:00